Fate Therapeutics Inc (NASDAQ:FATE)

23.58
Delayed Data
As of May 27
 +1.15 / +5.13%
Today’s Change
20.49
Today|||52-Week Range
97.43
-59.70%
Year-to-Date

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 84.00, with a high estimate of 135.00 and a low estimate of 42.00. The median estimate represents a +256.23% increase from the last price of 23.58.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Buy stock in Fate Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.83
Sales
$12.5M
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.97%
 
 
 
 
 
 
Growthannually -46.23%
 
 
 
 
 
 

Sales

Growthquarterly -32.27%
 
 
 
 
 
 
Growthannually -0.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.